ArticleInternational journal of public health2026
Epidemiological trends of type 2 diabetes in Middle East and North Africa, 1990-2023: global burden of disease data analysis.
Article in International journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study systematically evaluating temporal trends of type 2 diabetes (T2DM) prevalence, mortality, and DALY estimates from countries in MENA (Middle East and North Africa) region. Methods: The involved a secondary analysis of Global Burden of Disease (GBD) 2023 data regarding age-standardized prevalence, mortality, and DALY rates are calculated for men and women by country and sub-region using 1990 and 2023. Results: Overall, prevalence of T2DM increased from 5.6% in 1990 to 11.5% in 2023. Diabetes-related deaths, peaked between 2010 and 2015, declined to approximately 30 per 100,000 by 2023, disability burdens (DALY rates) rose, among men. Regional variations include rapid increases in Turkey, high rates in Levant, upward trends in North Africa (notably Egypt and Tunisia), and highest DALYs in Saudi Arabia and Bahrain (2,600 to 3,400 per 100,000). Iran and Yemen reported low but increasing disability burdens. Conclusion: T2DM has been consistently increasing over last 30 years in MENA region and has presented itself as a more debilitating and lethal chronic disease over this period. There is a wide range of variation between countries within the MENA region.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.